- cafead Apr 20, 2020 at 11:02: AM
via After delaying a CAR-T test and with time on its hands, Anixa Biosciences is working with Germany-based computational company OntoChem to find new antiviral meds for COVID-19.
It’s all very early-stage, but the pair hopes to tap into experimental antivirals in a speedy way to try to help kill off or at least dampen SARS-CoV-2, the virus causing the global COVID-19 pandemic.
article source
It’s all very early-stage, but the pair hopes to tap into experimental antivirals in a speedy way to try to help kill off or at least dampen SARS-CoV-2, the virus causing the global COVID-19 pandemic.
article source